Germ Cell Tumor Clinical Trials Database - Free Access to 14 Studies
Access comprehensive clinical trial information for Germ Cell Tumor through Pure Global AI's free database. This collection includes 14 clinical trials across multiple phases including Phase 2, Phase 3, N/A. Currently, 5 trials are actively recruiting participants.
Research for Germ Cell Tumor is being conducted in Slovakia, France, United States of America and 4+ other countries. Leading sponsors include National Cancer Institute, Slovakia and Gustave Roussy, Cancer Campus, Grand Paris. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated With High-dose Chemotherapy and Autologous Stem Cell Transplant
Disulfiram and Cisplatin in Refractory TGCTs.
Untitled Trial
Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
First Line TIP in Poor Prognosis TGCTs.
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors
Everolimus in Refractory Testicular Germ Cell Cancer
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Pure Global AI provides free access to 14 clinical trials studying Germ Cell Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 7+ countries.
Top research sponsors include National Cancer Institute, Slovakia, Gustave Roussy, Cancer Campus, Grand Paris, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, among others.